Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Equity (2020 - 2025)

Historic Return on Equity for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to 3.54%.

  • Celularity's Return on Equity rose 50900.0% to 3.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.54%, marking a year-over-year increase of 50900.0%. This contributed to the annual value of 2.33% for FY2024, which is 6900.0% down from last year.
  • Latest data reveals that Celularity reported Return on Equity of 3.54% as of Q3 2025, which was up 50900.0% from 4.75% recorded in Q2 2025.
  • Over the past 5 years, Celularity's Return on Equity peaked at 4.75% during Q2 2025, and registered a low of 33.4% during Q1 2025.
  • Over the past 5 years, Celularity's median Return on Equity value was 0.86% (recorded in 2022), while the average stood at 2.54%.
  • Within the past 5 years, the most significant YoY rise in Celularity's Return on Equity was 85700bps (2025), while the steepest drop was -291300bps (2025).
  • Over the past 5 years, Celularity's Return on Equity (Quarter) stood at 1.02% in 2021, then surged by 108bps to 0.08% in 2022, then crashed by -7154bps to 5.51% in 2023, then increased by 20bps to 4.43% in 2024, then skyrocketed by 180bps to 3.54% in 2025.
  • Its Return on Equity was 3.54% in Q3 2025, compared to 4.75% in Q2 2025 and 33.4% in Q1 2025.